Kovack Advisors, Inc. Stereotaxis, Inc. Transaction History
Kovack Advisors, Inc.
- $988 Million
- Q2 2025
A detailed history of Kovack Advisors, Inc. transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Kovack Advisors, Inc. holds 133,960 shares of STXS stock, worth $356,333. This represents 0.03% of its overall portfolio holdings.
Number of Shares
133,960
Previous 133,782
0.13%
Holding current value
$356,333
Previous $235,000
20.43%
% of portfolio
0.03%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding STXS
# of Institutions
95Shares Held
42.1MCall Options Held
21.9KPut Options Held
18.6K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$36.4 Million8.43% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.69MShares$12.5 Million5.81% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$9.42 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.3MShares$8.78 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.85MShares$7.59 Million14.02% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $199M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...